These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 19359987

  • 21. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH, Wolf H, Minarovits J.
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [Abstract] [Full Text] [Related]

  • 22. EBV in MS: guilty by association?
    Lünemann JD, Münz C.
    Trends Immunol; 2009 Jun; 30(6):243-8. PubMed ID: 19428300
    [Abstract] [Full Text] [Related]

  • 23. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
    Fernández-Menéndez S, Fernández-Morán M, Fernández-Vega I, Pérez-Álvarez A, Villafani-Echazú J.
    J Neurol Sci; 2016 Feb 15; 361():213-9. PubMed ID: 26810546
    [Abstract] [Full Text] [Related]

  • 24. Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis.
    Otto C, Oltmann A, Stein A, Frenzel K, Schroeter J, Habbel P, Gärtner B, Hofmann J, Ruprecht K.
    Neurology; 2011 Apr 12; 76(15):1316-21. PubMed ID: 21482946
    [Abstract] [Full Text] [Related]

  • 25. Autoimmune disease: A role for new anti-viral therapies?
    Dreyfus DH.
    Autoimmun Rev; 2011 Dec 12; 11(2):88-97. PubMed ID: 21871974
    [Abstract] [Full Text] [Related]

  • 26. Does Epstein-Barr virus infection in the brain drive the development of multiple sclerosis?
    Pender MP.
    Brain; 2009 Dec 12; 132(Pt 12):3196-8. PubMed ID: 20008341
    [No Abstract] [Full Text] [Related]

  • 27. Epstein-Barr virus and multiple sclerosis: association or causation?
    Pakpoor J, Giovannoni G, Ramagopalan SV.
    Expert Rev Neurother; 2013 Mar 12; 13(3):287-97. PubMed ID: 23448218
    [Abstract] [Full Text] [Related]

  • 28. Epstein-Barr virus and systemic lupus erythematosus.
    James JA, Harley JB, Scofield RH.
    Curr Opin Rheumatol; 2006 Sep 12; 18(5):462-7. PubMed ID: 16896283
    [Abstract] [Full Text] [Related]

  • 29. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS.
    Cancer Res; 1981 Nov 12; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [Abstract] [Full Text] [Related]

  • 30. CD21 positive B cell: a novel target for treatment of multiple sclerosis.
    Farjam M, Ebrahimpour A, Fakhraei B.
    Med Hypotheses; 2013 May 12; 80(5):556-7. PubMed ID: 23384704
    [Abstract] [Full Text] [Related]

  • 31. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.
    Pender MP, Csurhes PA, Lenarczyk A, Pfluger CM, Burrows SR.
    J Neurol Neurosurg Psychiatry; 2009 May 12; 80(5):498-505. PubMed ID: 19015225
    [Abstract] [Full Text] [Related]

  • 32. Epstein-Barr virus and multiple sclerosis: cellular immune response and cross-reactivity.
    Lindsey JW, Hatfield LM.
    J Neuroimmunol; 2010 Dec 15; 229(1-2):238-42. PubMed ID: 20826010
    [Abstract] [Full Text] [Related]

  • 33. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.
    Najafipoor A, Roghanian R, Zarkesh-Esfahani SH, Bouzari M, Etemadifar M.
    Cell Immunol; 2015 Mar 15; 294(1):9-12. PubMed ID: 25666504
    [Abstract] [Full Text] [Related]

  • 34. EBV and brain matter(s)?
    Ascherio A, Bar-Or A.
    Neurology; 2010 Apr 06; 74(14):1092-5. PubMed ID: 20237306
    [No Abstract] [Full Text] [Related]

  • 35. Does epstein-barr virus cause multiple sclerosis?
    Cook SD.
    Rev Neurol Dis; 2004 Apr 06; 1(3):115-23. PubMed ID: 16400268
    [Abstract] [Full Text] [Related]

  • 36. Gender and the Sex Hormone Estradiol Affect Multiple Sclerosis Risk Gene Expression in Epstein-Barr Virus-Infected B Cells.
    Keane JT, Afrasiabi A, Schibeci SD, Fewings N, Parnell GP, Swaminathan S, Booth DR.
    Front Immunol; 2021 Apr 06; 12():732694. PubMed ID: 34566997
    [Abstract] [Full Text] [Related]

  • 37. Epstein-Barr virus reactivation and multiple sclerosis.
    Torkildsen Ø, Nyland H, Myrmel H, Myhr KM.
    Eur J Neurol; 2008 Jan 06; 15(1):106-8. PubMed ID: 18042233
    [Abstract] [Full Text] [Related]

  • 38. The antibody response to Epstein-Barr virions is altered in multiple sclerosis.
    Lindsey JW, Khan U, Ansari W, Powell T, Wang YH, Guirguis MS.
    J Neuroimmunol; 2013 Jan 15; 254(1-2):146-53. PubMed ID: 23026221
    [Abstract] [Full Text] [Related]

  • 39. Epstein-Barr virus in pediatric multiple sclerosis.
    Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B.
    JAMA; 2004 Apr 21; 291(15):1875-9. PubMed ID: 15100207
    [Abstract] [Full Text] [Related]

  • 40. The role of EBV in MS pathogenesis.
    Christensen T.
    Int MS J; 2006 May 21; 13(2):52-7. PubMed ID: 16635422
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.